YAO LU

Dr. YAO LU

Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2009 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
YAO LUYAO LU
YAO LU
WSWeiwei Shi
Weiwei Shi
LJLei Jiang
Lei Jiang
QJQin Jianhua
Qin Jianhua
BLBingcheng Lin
Bingcheng Lin

11 December 2009 in Analytical Chemistry
Verified
Journal Article
Closed access
YAO LUYAO LU
YAO LU
WSWeiwei Shi
Weiwei Shi
JQJianhua Qin
Jianhua Qin
BLBingcheng Lin
Bingcheng Lin

2 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YAO LUYAO LU
YAO LU
QXQiong Xue
Qiong Xue
MEMarkus R. Eisele
Markus R. Eisele
ESEndah S. Sulistijo
Endah S. Sulistijo
KBKara Brower
Kara Brower
RFRong Fan
Rong Fan
Significance: We demonstrated codetection of 42 immune effector proteins in single cells, representing the highest multiplexing recorded to date for a single-cell secretion assay. Using this platform to profile differentiated macrophages stimulated with lipopolysaccharide reveals previously unobserved deep functional heterogeneity and varying levels of pathogenic activation, which is conserved throughout the cell activation process and prevails as it is extended to other Toll-like receptor (TLR) ligands and to primary human macrophages. The results indicate that the phenotypically similar cell population could still exhibit a large degree of intrinsic heterogeneity at the cell function level. This technology enables full-spectrum dissection of immune functional states in response to pathogenic stimulation and allows for more comprehensive and accurate monitoring of cellular immunity.

3 December 2019 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
JKJing Kong
Jing Kong
HTHongzhu Tian
Hongzhu Tian
FZFuyin Zhang
Fuyin Zhang
ZZZebing Zhang
Zebing Zhang
JLJiao Li
Jiao Li
TLTingjiao Liu
Tingjiao Liu
Objectives: Carcinoma-associated fibroblasts (CAFs) have been known to promote cancer progression by modifying the primary tumor microenvironment. We aimed to elucidate the intercellular communication between CAFs and secondary organs in salivary adenoid cystic carcinoma (SACC) metastasis. Methods: Pre-metastatic and metastatic animal models of SACC were established using extracellular vesicles (EVs) from CAFs and SACC cells. Lung fibroblasts (LFs) were treated with EVs and their transcriptomic alterations were identified by RNA sequencing. ITRAQ were performed to analyze EV cargos. TC I-15 was used to inhibit EV uptake by LFs and SACC lung metastasis in vivo. Results: Here, we show that CAF EVs induced lung pre-metastatic niche formation in mice and consequently increased SACC lung metastasis. The pre-metastatic niche induced by CAF EVs was different from that induced by SACC EVs. CAF EVs presented a great ability for matrix remodeling and periostin is a potential biomarker characterizing the CAF EV-induced pre-metastatic niche. We found that lung fibroblast activation promoted by CAF EVs was a critical event at the pre-metastatic niche. Integrin α2β1 mediated CAF EV uptake by lung fibroblasts, and its blockage by TC I-15 prevented lung pre-metastatic niche formation and subsequent metastasis. Plasma EV integrin β1 was considerably upregulated in the mice bearing xenografts with high risk of lung metastasis. Conclusions: We demonstrated that CAF EVs participated in the pre-metastatic niche formation in the lung. Plasma EV integrin β1 might be a promising biomarker to predict SACC metastasis at an early stage. An integrated strategy targeting both tumor and stromal cells is necessary to prevent SACC metastasis.

3 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SFShimeng Fang
Shimeng Fang
HTHongzhu Tian
Hongzhu Tian
XLXiancheng Li
Xiancheng Li
DJDong Jin
Dong Jin
XLXiaojie Li
Xiaojie Li
TLTingjiao Liu
Tingjiao Liu
Increasing attention has been attracted by exosomes in blood-based diagnosis because cancer cells release more exosomes in serum than normal cells and these exosomes overexpress a certain number of cancer-related biomarkers. However, capture and biomarker analysis of exosomes for clinical application are technically challenging. In this study, we developed a microfluidic chip for immunocapture and quantification of circulating exosomes from small sample volume and applied this device in clinical study. Circulating EpCAM-positive exosomes were measured in 6 cases breast cancer patients and 3 healthy controls to assist diagnosis. A significant increase in the EpCAM-positive exosome level in these patients was detected, compared to healthy controls. Furthermore, we quantified circulating HER2-positive exosomes in 19 cases of breast cancer patients for molecular classification. We demonstrated that the exosomal HER2 expression levels were almost consistent with that in tumor tissues assessed by immunohistochemical staining. The microfluidic chip might provide a new platform to assist breast cancer diagnosis and molecular classification.

1 February 2013 in Analytical Chemistry
Verified
Journal Article
Closed access
YAO LUYAO LU
YAO LU
JCJonathan J. Chen
Jonathan J. Chen
LMLuye Mu
Luye Mu
QXQiong Xue
Qiong Xue
YWYu Wu
Yu Wu
RFRong Fan
Rong Fan